'Egfr expression' diaporamas de présentation

Newer approaches to treatment of disseminated disease

UNKNOWN PRIMARY TUMORS: NEWER CONCEPTS AND APPROACHES Rome, March 5-6, 2010. Newer approaches to treatment of disseminated disease. Matteo Landriscina, MD PhD Assistant Professor of Clinical Oncology University of Foggia. EPIDEMIOLOGY. CUP constitutes 2-4% of all malignacies

499 views • 39 slides

Targeted therapies nella pratica clinica: Neoplasie del polmone

550 views • 37 slides

Gli inibitori di EGFR in associazione alla chemioterapia nei pazienti wild-type

CHEMO-IMMUNO-TARGET THERAPIES Tre strategie di trattamento nel NSCLC in stadio avanzato Camogli, 29-30 Aprile 2016. Gli inibitori di EGFR in associazione alla chemioterapia nei pazienti wild-type. Erika Rijavec UOS Tumori Polmonari Azienda Ospedaliera Universitaria San Martino IST

368 views • 36 slides

Redox NSAIDs and VEGF Terry Moody, Ph.D. NCI Center for Cancer Research Bldg. 31, Rm. 4A48 301-451-9451 moodyt@mail.nih.

Redox NSAIDs and VEGF Terry Moody, Ph.D. NCI Center for Cancer Research Bldg. 31, Rm. 4A48 301-451-9451 moodyt@mail.nih.gov. Lung Cancer kills over 150,000 patients in the U.S. annually. There are 45 Million current smokers and 45 Million ex-smokers in the U.S.

446 views • 27 slides

F. Lordick,* Y-K. Kang, P. Salman, S.C. Oh, G. Bodoky,

Clinical outcome according to tumor HER2 status and EGFR expression in advanced gastric cancer patients from the EXPAND study. F. Lordick,* Y-K. Kang, P. Salman, S.C. Oh, G. Bodoky, G.P. Kurteva, C.D. Volovat, V. Moiseyenko, A. Sawaki, J.O. Park, V.A. Gorbunova, H. Goette,

321 views • 19 slides